** Shares of Consun Pharmaceutical Group Ltd 1681.HK rise
8.7% to HK$5.47, biggest intraday jump since March 23
** Stock among 30 top gainers on the Hong Kong bourse, hits
highest since June 11
** Guangdong-based co says its unit has entered into a
strategic cooperation agreement with WuXi AppTec (Shanghai) Co
Ltd, a subsidiary of WuXi AppTec Co Ltd 603259.SS 2359.HK ,
for R&D of certain innovative drugs and other new drugs for use
in treating kidney disease (https://bit.ly/3xRitDA)
** Hong Kong shares of Wuxi AppTec climbs 0.4% while
Shanghai shares rise 1.8%
** The Hong Kong Hang Seng Commerce & Industry Index .HSNC
falls 1.6%, while the healthcare index .HSCIH gains 0.7%
** Both the Hang Seng China Enterprises Index .HSCE and
the benchmark index .HSI drop 1.8%
** As of last close, the stock of Consun had soared 64.9%
this year
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))